IP Verse

Protein Purification Method - EP2261230

The patent EP2261230 was granted to Chugai Seiyaku Kabushiki Kaisha on May 10, 2017. The application was originally filed on Sep 11, 2003 under application number EP10180577A. The patent is currently recorded with a legal status of "Revoked".

EP2261230

CHUGAI SEIYAKU KABUSHIKI KAISHA
Application Number
EP10180577A
Filing Date
Sep 11, 2003
Status
Revoked
Mar 31, 2023
Grant Date
May 10, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (7)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BAXALTAFeb 12, 2018HOFFMANN EITLEADMISSIBLE
DILGFeb 12, 2018MAIWALDADMISSIBLE
EDERFeb 9, 2018EDERADMISSIBLE
HOFFMANN EITLEFeb 9, 2018HOFFMANN EITLEADMISSIBLE
NEUEFEINDFeb 9, 2018MAIWALDADMISSIBLE
TAORMINOFeb 8, 2018-ADMISSIBLE
GLAXO GROUPFeb 7, 2018KNIGHTADMISSIBLE

Patent Citations (52) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0239400
DESCRIPTIONJPH0159878B
DESCRIPTIONJPH05504579
DESCRIPTIONJPH08151398
DESCRIPTIONJPH08506023
DESCRIPTIONJPH0899902
DESCRIPTIONJPS6112288
DESCRIPTIONWO9012874
DESCRIPTIONWO9201047
DESCRIPTIONWO9203918
DESCRIPTIONWO9219759
DESCRIPTIONWO9220791
DESCRIPTIONWO9306213
DESCRIPTIONWO9311236
DESCRIPTIONWO9312227
DESCRIPTIONWO9319172
DESCRIPTIONWO9402602
DESCRIPTIONWO9425585
DESCRIPTIONWO9501438
DESCRIPTIONWO9515388
DESCRIPTIONWO9602576
DESCRIPTIONWO9633735
DESCRIPTIONWO9634096
DESCRIPTIONWO9813388
DESCRIPTIONWO9814580
DESCRIPTIONWO9951743
EXAMINATIONEP1380589
EXAMINATIONWO02072615
OPPOSITIONEP0166623
OPPOSITIONEP0628639
OPPOSITIONEP0893450
OPPOSITIONEP0960936
OPPOSITIONEP0962467
OPPOSITIONEP1380589
OPPOSITIONEP1561756
OPPOSITIONJP2002265609
OPPOSITIONUS5110910
OPPOSITIONUS5840297
OPPOSITIONUS6127526
OPPOSITIONWO02072615
OPPOSITIONWO2004024752
OPPOSITIONWO9522389
OPPOSITIONWO9635710
OTHEREP1380589
OTHERWO02072615
SEARCHEP0344796
SEARCHEP0628639
SEARCHEP0893450
SEARCHEP0960936
SEARCHEP0962467
SEARCHUS6096872
SEARCHWO9522389

Non-Patent Literature (NPL) Citations (45) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- "Ion Exchange Chromatography Principles and Methods", PHARMACIA (LATTERLY AMERSHAM BIOSCIENCES, pages 52 - 56
DESCRIPTION- SATO, K. ET AL., CANCER RES., (1993), vol. 53, pages 851 - 856
OPPOSITION- ARANHA-CREADO et al., "Virus retention by a hydrophilic triple-layer PVDF microporous membrane filter", PDA J Pharm Sci Technol, (19970500), vol. 51, no. 3, pages 119 - 124, XP055315717
OPPOSITION- ARANHA-CREADO et al., "Virus Retention by a Hydrophilic Triple-Layer PVDF Microporous Membrane Filter", PDA J Pharm Sci Technol., (19970600), vol. 51, no. 3, pages 119 - 124, XP055315717
OPPOSITION- BRORSON et al., "Bracketed Generic Inactivation of Rodent Retroviruses by Low pH Treatmentfor Monoclonal Antibodies and Recombinant Proteins", Biotech. Bioeng, (20030500), vol. 82, no. 3, pages 321 - 329, XP002576451
OPPOSITION- CAMPBELL et al., Biology, Addison Wesley Longman, (19990000), pages 319 - 330, XP055315940
OPPOSITION- "Citric acid", Wikipedia, the free encyclopedia, (20180102), pages 1 - 10, URL: https://en.wikipedia.org/w/index.php?title=Citric_acid&oldid=818317313, (20180206), XP055464385
OPPOSITION- FLOYD et al., "Viral Aggregation: Buffer Effects in the Aggregation of Poliovirus and Reovirus at Low and High pH", Appl Environ Microbiol, (19790000), vol. 38, no. 3, pages 395 - 401, XP055307511
OPPOSITION- FLOYD et al., "Viral Aggregation: Buffer Effects in the Aggregation of Poliovirus and Reovirus at Low and High pH", Appl. Env. Microb., (19790900), vol. 38, no. 3, pages 395 - 401, XP055307511
OPPOSITION- FLOYD, R. et al., "Viral Aggregation: Buffer Effects in the Aggregation of Poliovirus and Reovirus at Low and High pH", Applied and Environmental Microbiology, (19790900), vol. 38, no. 3, pages 395 - 401, XP055307511
OPPOSITION- "Guide to Conductivity and Dissolved Oxygen", Mettler-Toledo, (19990525), pages 1 - 19, XP055464388
OPPOSITION- LIDE D. R., CRC Handbook of Chemistry and Physics, Taylor & Francis Group, (20060000), page 5-72, XP055464300
OPPOSITION- Mettler-Toledo AG, "A Guide to Conductivity Measurement. Theory and Practice of Conductivity Applications", Conductivity Guide, (20130800), XP055315881
OPPOSITION- MICHEN et al., "Isoelectric points of viruses", Journal of Applied Microbiology, (20100000), vol. 109, no. 2, pages 388 - 397, XP055314887
OPPOSITION- MICHEN et al., "lsoelectric points of viruses", Journal of Applied Microbiology, (20100122), vol. 109, no. 2, pages 388 - 397, XP055314887
OPPOSITION- NEIL A. CAMPBELL et al., Biology. 5th ed., Addison Wesley Longman, (19990000), pages 319 - 330, XP055315940
OPPOSITION- OZAKI et al., "Humanized Anti-HM1.24 Antibody Mediates Myeloma Cell CytotoxicityThat Is Enhanced by Cytokine Stimulation of Effector Cells", Blood, (19990000), vol. 93, no. 11, pages 3922 - 3930, XP002942079
OPPOSITION- "Points to consider in the manufacture and testing of monoclonal antibody products for human use", Food and Drug Administration, Rockville , MD, (19970000), pages 1 - 50, XP055457764
OPPOSITION- R. FLOYD et al., "Aggregation of Poliovirus and Reovirus by Dilution in Water", Appl. Env. Microb., (19770100), vol. 33, no. 1, pages 159 - 167, XP055315697
OPPOSITION- R. FLOYD et al., "Viral Aggregation: Buffer Effects in the Aggregation of Poliovirus and Reovirus at Low and High pH", Appl. Env. Microb., (19790000), vol. 38, no. 3, pages 395 - 401, XP055307511
OPPOSITION- Rosemount Analytical, "Conductance Data For Commonly Used Chemicals", Emerson, http://www2.emersonprocess.com/siteadmincenter/pm%20Rosemount%20Analytical%20Documents/LIQ_MAN_6039_Conductance_Data_Commonly_Used_Chemicals.pdf, (20101200), XP055464386
OPPOSITION- "Scaleup and Virus Clearance Studies on Virus Filtration in Monoclonal Antibody Manufacture", HUANG et al., Membrane Separations in Biotechnology, NY, Marcel Dekker, (20010000), pages 327 - 350, XP055315868
OPPOSITION- "Scaleup and Virus Clearance Studies on Virus Filtration in Monoclonal Antibody Manufacture", P. U. HUANG et al., Membrane Separations in Biotechnology, Marcel Dekker, (20010000), pages 327 - 350, XP055315868
OPPOSITION- VOET and Voet, Biochemistry. 2nd ed., John Wiley & Sons, (19950000), page 112, XP055464303
OPPOSITION- PRIN et al., "Isoelectric restriction of human immunoglobulin isotypes", Biochim. Biophys. Acta, (19950000), vol. 1243, no. 2, pages 287 - 290, XP055307495
OPPOSITION- GREBER et al., "Mechanisms of virus uncoating", Trends in Microbiology, (19940000), vol. 2, no. 2, doi:doi:10.1016/0966-842X(94)90126-0, pages 52 - 56, XP025906629
OPPOSITION- GOYON et al., "Determination of isoelectric points and relative charge variants of 23 therapeutic monoclonal antibodies", J Chromatogr B, (20171015), vol. 1065, pages 119 - 128, XP085233861
OPPOSITION- GOYON et al., "Determination of isoelectric points and relative charge variants of 23 therapeutic monoclonal antibodies", Journal of Chromatography B, (20170000), vol. 1065, pages 119 - 128, XP085233861
OPPOSITION- VALDES et al., "Chromatographic removal combined with heat, acid and chaotropic inactivation of four model viruses", Journal of Biotechnology, (20020000), vol. 96, no. 3, pages 251 - 258, XP002318532
OPPOSITION- HERATH et al., "Removal of viruses by microfiltration membranes at different solution environments", Wat Sci. Tech., (19990000), vol. 40, no. 4-5, pages 331 - 338, XP055307422
OPPOSITION- MERTEN, "Virus contaminations of cell cultures - A biotechnological view", Cytotechnology, (20020600), vol. 39, no. 2, pages 91 - 116, XP019236736
OPPOSITION- O.-W. MERTEN, "Virus contaminations of cell cultures - A biotechnological view", Cytotechnology, vol. 39, no. 2, (20020600), pages 91 - 116, (20020700), XP019236736
OPPOSITION- BEST, "PRECIPITATION OF THE TOBACCO MOSAIC VIRUS COMPLEX AT ITS ISOELECTRIC POINT", Journal of Experimental Biology and Medical Science, (19360300), vol. 14, no. 1, pages 1 - 13, XP055464293
OPPOSITION- OMAR et al., "Virus inactivation by pepsin treatment at pH 4 of IgG solutions: factors affecting the rate of virus inactivation", Transfusion, (19960000), vol. 36, no. 10, pages 866 - 872, XP009005370
OPPOSITION- OMAR et al., "Virus inactivation by pepsin treatment at pH 4 of IgG solutions: factors affecting the rate of virus inactivation", Transfusion, (19961000), vol. 36, no. 10, pages 866 - 872, XP009005370
OPPOSITION- FAHRNER et al., "Industrial Purification of Pharmaceutical Antibodies: Development, Operation, and Validation of Chromatography Processes", Biotech. and Genetic Engineering Reviews, (20010700), vol. 18, no. 12, pages 301 - 327, XP003035628
OPPOSITION- FAHRNER et al., "Industrial Purification of Pharmaceutical Antibodies: Development, Operation, and Validation of Chromatography Processes", Biotech. and Genetic Engineering Reviews, (20010700), vol. 18, pages 301 - 327, XP008034714
OPPOSITION- FAHRNER et al., "Industrial Purification of Pharmaceutical Antibodies: Development, Operation, and Validation of Chromatography Processes", Biotechnology and Genetic Engineering Reviews, (20010000), vol. 18, pages 301 - 327, XP008034714
OPPOSITION- FAHRNER et al., "Industrial Purification of Pharmaceutical Antibodies: Development, Operation and Validation of Chromatography Processes", Biotechnology and Genetic Engineering Reviews, (20010700), vol. 18, doi:10.1080/02648725.2001.10648017, pages 301 - 327, XP008034714
OPPOSITION- FAHRNER et al., "Industrial Purification of Pharmaceutical Antibodies: Development, Operation, and Validation of Chromatography Processes", Biotechnology and Genetic Engineering Reviews, (20010700), vol. 18, pages 301 - 327, XP003035628
OTHER- ATKINS P.W., PHYSICAL CHEMISTRY, 4TH ED., OXFORD UNIVERSITY PRESS, (1990), pages 23-24,250 - 252, ISBN 9780716720737, XP003035881
OTHER- USP, "645 WATER CONDUCTIVITY", UNITED STATES PHARMACOPEIA CONVENTION, (2014), pages 1 - 3, URL: HTTPS://HMC.USP.ORG/SITES/DEFAULT/FILES/DOCUMENTS/HMC/GCS-PDFS/C645.PDF, XP055199178
SEARCH- ARANHA-CREADO H ET AL, "CLEARANCE OF MURINE LEUKAEMIA VIRUS FROM MONOCLONAL ANTIBODY SOLUTIONS BY A HYDROPHILIC PVDF MICROPOROUS MEMBRANE FILTER", BIOLOGICALS, ACADEMIC PRESS LTD., LONDON, GB LNKD- DOI:10.1006/BIOL.1998.0130, (19980101), vol. 26, ISSN 1045-1056, pages 167 - 172, XP001543186 [X] 21 * page 168, column 2, line 8 - page 169, column 1, line 15 *
SEARCH- OCTAAF J. M. BOS ET AL., "VIRUS VALIDATION OF pH 4-TREATED HUMAN IMMUNOGLOBULIN PRODUCTS PRODUCED BY THE COHN FRACTIONATION PROCESS", BIOLOGICALS, (199812), vol. 26, no. 4, pages 267 - 276, XP002389916 [X] 1,3-8,10 * page 267, paragraph 1 - page 268, paragraph 6; table 4 * * page 267, paragraph 1 - page 268, paragraph 6 *
SEARCH- LYDERSEN B K ET AL, "ACID PRECIPITATION OF MAMMALIAN CELL FERMENTATION BROTH", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, NEW YORK ACADEMY OF SCIENCES, NEW YORK, NY, US, (19941130), vol. 745, ISSN 0077-8923, pages 222 - 231, XP009033271 [X] 1,7,9,10 * page 222 - page 223; figures 1-5 * * page 222, paragraph 3 * * page 226, paragraph 1; figure 4 * * page 222, paragraph 1 - page 223, paragraph 6; figures 1-5 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents